Skip to main content

Table 3 Association of calculated threshold of main pancreatic duct (MPD) with malignancy in head-neck intraductal papillary mucinous neoplasms (IPMNs)

From: Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail

 

Univariate analysis

Multivariate analysis

OR

P value

OR

P value

MPD diameter (≥ 6.5 mm vs. < 6.5 mm)

12.73

(5.04–32.16)

 < 0.001

14.14

(4.61–43.39)

 < 0.01

Size (≥ 30 mm vs. < 30 mm)

3.63

(1.48–8.89)

0.005

2.39

(0.77–7.45)

0.13

CA19-9 (≥ 37 U/ml vs. < 37 U/ml)

3.30

(1.39–7.80)

0.006

3.68

(1.05–12.87)

0.04

Mural nodule (yes vs. no)

2.93

(1.03–8.36)

0.04

1.77

(0.45–7.00)

0.43

Diabetes Mellitus (yes vs. no)

5.07

(1.80–14.31)

0.002

2.01

(0.51–7.92)

0.32

CEA (≥ 5 vs. < 5 ng/ml)

4.02

(1.31–12.32)

0.015

1.23(0.23–8.68)

0.39

  1. CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, OR odds ratio
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us